MPO and colitis: Compared with the controls, 7-DHC-treated colitis mice showed less body weight loss, lower disease activity index (DAI) scores, longer colons, and lower myeloperoxidase activity, indicating that 7-DHC alleviated experimental colitis with circadian disruption (Fig. 1g–k).